Hepatology

By targeting the gut-liver axis, administration of L. reuteri or ILA could become a novel therapeutic approach to prevent TACE-LI.

Discover a study showing how PEth levels identify alcohol use and predict adverse outcomes in MASLD, MetALD, and ALD patients.

The DRIVE-C study in Haiphong, Vietnam, evaluated a community-based strategy to screen PWID for HCV and provide access to direct-acting antivirals.

A randomised controlled trial examined the effectiveness of facilitated telemedicine for hepatitis C virus treatments.

A 12-month randomised controlled trial investigated curcumin supplementation in Type 2 diabetes treatment, specifically its effects on liver steatosis.

The study examined transcriptome data from patients with HBV-induced acute liver failure and healthy controls, identifying key genes and pathways linked to disease progression.

Interestingly, liver transplant recipients did not experience excess mortality, likely due to restored liver function post-transplant.

Discover a study highlighting how small-incision large-expansion improves PAD treatment outcomes, offering safer, faster stone removal and preserved sphincter function.